Clinical mycology in Latin America and the Caribbean: A snapshot of diagnostic and therapeutic capabilities.
antigen detection
diagnosis
galactomannan
mycology
survey
Journal
Mycoses
ISSN: 1439-0507
Titre abrégé: Mycoses
Pays: Germany
ID NLM: 8805008
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
31
12
2018
accepted:
03
01
2019
pubmed:
8
1
2019
medline:
30
4
2019
entrez:
8
1
2019
Statut:
ppublish
Résumé
Despite the existence of endemic mycoses in Latin America and the Caribbean, in addition to a large population of patients at risk for invasive mycoses, the capability of medical centres to perform a proper diagnosis in mycology has not been studied in the region. Moreover, availability of antifungal drugs in the region is unknown. Here, we report the results of a survey involving 129 centres in 24 countries. Only 9% of centres would have the potential to apply for the minimum standards in mycology, as determined by the European Confederation of Medical Mycology. There is an urgent need to improve diagnostic conditions in Latin America and the Caribbean, as well as providing access to safer and more efficacious antifungal drugs.
Substances chimiques
Antifungal Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
368-373Informations de copyright
© 2019 Blackwell Verlag GmbH.